“UniQure’s AMT Clinical Trial: Enrollment Complete and Positive Recommendation from Data Monitoring Committee!”

Exciting News from the Independent Data Monitoring Committee! What does this mean? Recently, the Independent Data Monitoring Committee has recommended proceeding with dosing of the second cohort after a planned safety assessment. This is great news for the research team and the participants involved in the study. The committee’s recommendation shows that the initial safety…

Read More

“Meet the Newest Addition to Allegro MicroSystems’ Board of Directors: Dr. Krishna Palepu!”

Allegro MicroSystems Welcomes Harvard Business School Professor to Board of Directors A New Addition to the Allegro Family It’s not every day that a global leader in power and sensing semiconductor solutions like Allegro MicroSystems, Inc. announces a new addition to its Board of Directors. But that’s exactly what happened on January 31, 2025, when…

Read More

“Get Ready to Geek Out: Gossamer Bio’s Exciting Clinical and Preclinical Data at the Pulmonary Vascular Research Institute’s 2025 Annual Congress!”

Welcome to the San Diego Pulmonary Vascular Research Institute Annual Congress! Let’s Talk about Seralutinib and Its Impact on PAH and PH-ILD Hey there, fellow science enthusiasts! If you haven’t heard yet, Gossamer Bio, Inc. recently made a splash at the Pulmonary Vascular Research Institute Annual Congress in San Diego. They unveiled some exciting news…

Read More

“Attention Investors: Important Reminder from Bronstein, Gewirtz, and Grossman LLC Regarding MQ Stock”

Class Action Lawsuit Filed Against Marqeta, Inc. New York, NY / Access Newswire / February 3, 2025 Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marqeta, Inc. (“Marqeta” or “the Company”) (NASDAQ:MQ) and certain of its officers. This lawsuit seeks to recover…

Read More

Apogee Therapeutics Announces First Patient Dosed in Phase 2 APEX Trial for APG777 in Moderate to Severe Atopic Dermatitis

Enrollment of Phase 2 Part A Completed Ahead of Schedule for APG777 in Patients with AD Exciting News for Apogee Therapeutics, Inc. Apogee Therapeutics, Inc., a clinical-stage biotechnology company, has achieved a significant milestone with the completion of enrollment in the Part A portion of the Phase 2 APEX clinical trial for APG777. The trial,…

Read More

“Unleashing the Power of Resources: Talons’ 2024 Successes to Revolutionize U.S. Critical Minerals Supply Chains in 2025 and Beyond”

Progress in Minnesota’s Environmental Review Process and Exploration Successes Feasibility Design Basis for Tamarack Mine and North Dakota Minerals Processing Facility Department of Energy Backing Talon’s Ventures It’s an exciting time for the mining industry in the United States, particularly for Talon, a company that has recently achieved significant milestones in their exploration ventures. Thanks…

Read More

“Gold and Antimony: The Dynamic Duo of New Zealand’s Critical Minerals List! RUA GOLD Spills the Tea on Reefton’s Antimony Potential”

Well, Well, Well… Look Who’s Off to New Zealand! By: Your Friendly Neighborhood Blogger Vancouver, British Columbia–(Newsfile Corp. – February 3, 2025) – Rua Gold Inc. (TSXV: RUA) (OTCQB: NZAUF) (WKN: A40QYC) (“RUA GOLD” or the “Company”) executives attended the launch event for the Minerals Strategy for New Zealand to 2040 and Critical Minerals List…

Read More